scholarly journals TRANSCATHETER VALVE-IN-VALVE IMPLANTATION OF AN EDWARDS-SAPIEN 3 IN THE TRICUSPID POSITION FOR SEVERE BIOPROSTHETIC TRICUSPID STENOSIS

2018 ◽  
Vol 71 (11) ◽  
pp. A2305
Author(s):  
Carly Fabrizio ◽  
Pragya Ranjan ◽  
Neil Wimmer ◽  
Avinash Chandra
Keyword(s):  
Edwards Sapien ◽  
Valve In Valve ◽  
Sapien 3 ◽  
Transcatheter Valve ◽  
Valve Implantation

Transapical Transcatheter Mitral Valve-in-Valve Implantation Using an Edwards SAPIEN 3 Valve

2017 ◽  
Vol 26 (4) ◽  
pp. e19-e21 ◽  
Author(s):  
Cheng He ◽  
Gregory Scalia ◽  
Darren L. Walters ◽  
Andrew Clarke
Keyword(s):  
Mitral Valve ◽  
Edwards Sapien ◽  
Valve In Valve ◽  
Sapien 3 ◽  
Valve Implantation

scholarly journals Transcatheter Valve-in-Valve Implantation Edwards Sapien XT in a Direct Flow Valve after Early Degeneration

Authorea ◽  
2020 ◽  
Author(s):  
Bilge Duran Karaduman ◽  
H seyin Ayhan ◽  
Serkan Bulguro lu ◽  
Telat Keles ◽  
Engin Bozkurt
Keyword(s):  
Direct Flow ◽  
Edwards Sapien ◽  
Valve In Valve ◽  
Transcatheter Valve ◽  
Valve Implantation ◽  
Flow Valve

scholarly journals Numerical models for assessing the risk of leaflet thrombosis post-transcatheter aortic valve-in-valve implantation

2020 ◽  
Vol 7 (12) ◽  
pp. 201838
Author(s):  
Romina Plitman Mayo ◽  
Halit Yaakobovich ◽  
Ariel Finkelstein ◽  
Shawn C. Shadden ◽  
Gil Marom
Keyword(s):  
High Risk ◽  
Aortic Valve ◽  
Numerical Models ◽  
Aortic Valves ◽  
Transcatheter Aortic Valve ◽  
Edwards Sapien ◽  
Valve In Valve ◽  
Sapien 3 ◽  
Valve Implantation ◽  
Numerical Approaches

Leaflet thrombosis has been suggested as the reason for the reduced leaflet motion in cases of hypoattenuated leaflet thickening of bioprosthetic aortic valves. This work aimed to estimate the risk of leaflet thrombosis in two post-valve-in-valve (ViV) configurations, using five different numerical approaches. Realistic ViV configurations were calculated by modelling the deployments of the latest version of transcatheter aortic valve devices (Medtronic Evolut PRO, Edwards SAPIEN 3) in the surgical Sorin Mitroflow. Computational fluid dynamics simulations of blood flow followed the dry models. Lagrangian and Eulerian measures of near-wall stagnation were implemented by particle and concentration tracking, respectively, to estimate the thrombogenicity and to predict the risk locations. Most of the numerical approaches indicate a higher leaflet thrombosis risk in the Edwards SAPIEN 3 device because of its intra-annular implantation. The Eulerian approaches estimated high-risk locations in agreement with the wall sheer stress (WSS) separation points. On the other hand, the Lagrangian approaches predicted high-risk locations at the proximal regions of the leaflets matching the low WSS magnitude regions of both transcatheter aortic valve implantation models and reported clinical and experimental data. The proposed methods can help optimizing future designs of transcatheter aortic valves with minimal thrombotic risks.

Transapical Transcatheter Mitral Valve-In-Valve Implantation Using an Edwards SAPIEN 3 Valve

2018 ◽  
Vol 27 (3) ◽  
pp. e23-e24
Author(s):  
Javier Gualis ◽  
Rodrigo Estévez-Loureiro ◽  
David Alonso ◽  
Jose Manuel Martínez-Comendador ◽  
Elio Martín ◽  
...  
Keyword(s):  
Mitral Valve ◽  
Edwards Sapien ◽  
Valve In Valve ◽  
Sapien 3 ◽  
Valve Implantation

Transcatheter valve‐in‐valve implantation Edwards Sapien XT in a direct flow valve after early degeneration

2020 ◽  
Vol 35 (12) ◽  
pp. 3592-3595
Author(s):  
Bilge Duran Karaduman ◽  
Hüseyin Ayhan ◽  
Serkan Bulguroğlu ◽  
Telat Keleş ◽  
Engin Bozkurt
Keyword(s):  
Direct Flow ◽  
Edwards Sapien ◽  
Valve In Valve ◽  
Transcatheter Valve ◽  
Valve Implantation ◽  
Flow Valve

Transcatheter valve-in-valve implantation with the Edwards SAPIEN in patients with bioprosthetic heart valve failure: the Milan experience

2012 ◽  
Vol 7 (11) ◽  
pp. 1275-1284 ◽  
Author(s):  
Azeem Latib ◽  
Alfonso Ielasi ◽  
Matteo Montorfano ◽  
Francesco Maisano ◽  
Alaide Chieffo ◽  
...  
Keyword(s):  
Heart Valve ◽  
Bioprosthetic Heart Valve ◽  
Edwards Sapien ◽  
Valve In Valve ◽  
Transcatheter Valve ◽  
Valve Implantation

scholarly journals Transvenous Transcatheter Valve-in-Valve Implantation after Bioprosthetic Tricuspid Valve Failure

2014 ◽  
Vol 41 (5) ◽  
pp. 507-510 ◽  
Author(s):  
Ali Mortazavi ◽  
Ross M. Reul ◽  
Leon Cannizzaro ◽  
Kathryn G. Dougherty
Keyword(s):  
Tricuspid Valve ◽  
Shortness Of Breath ◽  
Tricuspid Valve Replacement ◽  
Thoracic Surgical Procedures ◽  
Edwards Sapien ◽  
Cardiology Clinic ◽  
History Of ◽  
Valve In Valve ◽  
Transcatheter Valve ◽  
Valve Implantation

We describe the case of a 38-year-old man with a history of metastatic testicular cancer who had undergone multiple thoracic surgical procedures, including tricuspid valve replacement with a bioprosthetic valve as a result of tricuspid involvement of his malignancy. He presented at our outpatient cardiology clinic with worsening fatigue, shortness of breath, and peripheral edema, investigation of which revealed severe tricuspid bioprosthesis stenosis with central regurgitation. Because of the patient's medical history, he was considered to be a high-risk surgical candidate. Therefore, transcatheter tricuspid valve-in-valve implantation of a 26-mm Edwards Sapien® valve was attempted through a transjugular approach. The procedure restored tricuspid valvar competence and substantially improved the patient's symptoms. We discuss the technical aspects of this case and briefly review the usefulness of the valve-in-valve technique in the tricuspid position.

scholarly journals Transcatheter Mitral Valve Replacement with the Edwards Sapien 3 Valve

2017 ◽  
Vol 44 (4) ◽  
pp. 269-273 ◽  
Author(s):  
Biswajit Kar ◽  
Angelo Nascimbene ◽  
Igor D. Gregoric ◽  
Manish Patel ◽  
Pranav Loyalka
Keyword(s):  
Mitral Valve ◽  
Valve Replacement ◽  
Mitral Valve Replacement ◽  
Mitral Valve Stenosis ◽  
Transcatheter Mitral Valve Replacement ◽  
Edwards Sapien ◽  
Sapien 3 ◽  
Transcatheter Valve ◽  
Valve Implantation ◽  
Surgical Valve Replacement

We describe the case of a 57-year-old man who had severe mitral valve stenosis and regurgitation without significant annular calcification. He was not a candidate for surgical valve replacement or repair because of his substantial comorbid conditions, overall frailty, and elevated surgical risk. He underwent successful transcatheter mitral valve replacement of his native mitral valve with compassionate, off-label use of an Edwards Sapien 3 valve. A search of the literature produced no other cases like ours, which represents a further evolution of the transcatheter valve implantation concept. Further studies are needed to help define accurate valve sizing, intraprocedural positioning, and long-term device stability, as well as to determine which patients might benefit from this commercially available valve. In the meantime, our findings could present a means of treating patients who have no other options.

Sign in / Sign up

Export Citation Format

Share Document